MetaCap

ACADIA Pharmaceuticals Insider Trades

NASDAQ: ACADHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.78+0.20 (+1.02%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
24 · $3.40M
Shares bought / sold
0 / 141.64K
Net activity
Net selling $3.4 million

ACADIA Pharmaceuticals insider activity

Over the last 12 months, ACADIA Pharmaceuticals insiders reported 51 transactions on SEC Form 4: 0 open-market purchases and 24 sales. Insiders bought $0 and sold $3.4 million worth of stock, for net insider selling of $3.4 million. The largest seller was Schneyer Mark C., with $1.1 million in reported sales.

The most recent filing shows Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) reporting a transaction in 14,292 shares at $17.84 on Aug 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ACAD's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ACAD insider transactions

ACADIA Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Aug 6, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale9,292$272.60KForm 4
Aug 6, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale5,000$145.00KForm 4
Aug 6, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROption exercise14,292$254.97KForm 4
Aug 5, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale5,849$169.64KForm 4
Aug 5, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROption exercise5,849$104.35KForm 4
Jul 30, 2026Thompson Elizabeth H.Z.EVP, Head of Research & DevSale50$1.31KForm 4
Jul 30, 2026Thompson Elizabeth H.Z.EVP, Head of Research & DevSale16,508$431.35KForm 4
Jul 29, 2026Thompson Elizabeth H.Z.EVP, Head of Research & DevOption exercise32,272—Form 4
Jun 26, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSale11,421$297.91KForm 4
May 29, 2026Daly James MDirectorOption exercise8,107—Form 4
May 29, 2026GAROFALO ELIZABETH A.DirectorOption exercise8,107—Form 4
May 29, 2026Poole JonathanDirectorOption exercise2,010—Form 4
May 29, 2026Brege LauraDirectorOption exercise8,107—Form 4
May 29, 2026Ndu AdoraDirectorOption exercise8,107—Form 4
May 29, 2026HARRIGAN EDMUNDDirectorOption exercise8,107—Form 4
May 29, 2026BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirectorAward18,622—Form 4
May 29, 2026BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirectorAward18,622—Form 4
May 26, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSale5,401$114.39KForm 4
May 4, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale3,506$76.40KForm 4
May 4, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSale1,332$29.02KForm 4
May 1, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROption exercise6,815—Form 4
May 1, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICEROption exercise2,596—Form 4
Apr 7, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSale1,030$22.87KForm 4
Apr 7, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale2,709$60.14KForm 4
Apr 5, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICEROption exercise2,010—Form 4
Apr 5, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROption exercise5,276—Form 4
Mar 26, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSale12$260.70Form 4
Mar 26, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSale1,097$23.75KForm 4
Mar 26, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale37$803.54Form 4
Mar 26, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale3,171$68.65KForm 4
Mar 25, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICEROption exercise2,142—Form 4
Mar 25, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICERSale833$17.88KForm 4
Mar 25, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROption exercise6,178—Form 4
Mar 25, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale4,177$89.68KForm 4
Mar 25, 2026Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECSale3,844$82.53KForm 4
Mar 25, 2026Thompson Elizabeth H.Z.EVP, Head of Research & DevSale3,435$73.75KForm 4
Mar 25, 2026Owen Adams CatherineChief Executive OfficerSale11,641$249.93KForm 4
Mar 24, 2026Kihara JamesPRINCIPAL ACCOUNTING OFFICEROption exercise1,627—Form 4
Mar 24, 2026Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROption exercise8,138—Form 4
Mar 24, 2026Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECOption exercise7,515—Form 4
Mar 24, 2026Thompson Elizabeth H.Z.EVP, Head of Research & DevOption exercise6,715—Form 4
Mar 24, 2026Owen Adams CatherineChief Executive OfficerOption exercise23,509—Form 4
Feb 9, 2026Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECSale6,950$162.49KForm 4
Feb 6, 2026Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECOption exercise12,944—Form 4
Nov 18, 2025Kihara JamesPRINCIPAL ACCOUNTING OFFICERSale4,084$96.75KForm 4
Nov 18, 2025Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale10,262$243.11KForm 4
Nov 17, 2025Kihara JamesPRINCIPAL ACCOUNTING OFFICEROption exercise3,966—Form 4
Nov 17, 2025Kihara JamesPRINCIPAL ACCOUNTING OFFICEROption exercise3,966—Form 4
Nov 17, 2025Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROption exercise9,913—Form 4
Nov 17, 2025Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROption exercise9,913—Form 4
Nov 10, 2025Daly James MDirectorSale30,000$670.98KForm 4
Sep 15, 2025Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale3,498$82.73KForm 4
Sep 12, 2025Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAward6,815—Form 4
Sep 2, 2025GAROFALO ELIZABETH A.DirectorSale1,600$41.56KForm 4
Aug 18, 2025Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERSale22,000$554.02KForm 4
Jun 4, 2025Brege LauraDirectorSale14,446$314.63KForm 4
May 29, 2025Daly James MDirectorOption exercise9,387—Form 4
May 29, 2025GAROFALO ELIZABETH A.DirectorOption exercise9,387—Form 4
May 29, 2025Ndu AdoraDirectorOption exercise9,387—Form 4
May 29, 2025SOLAND DANIEL BDirectorOption exercise9,387—Form 4
May 29, 2025HARRIGAN EDMUNDDirectorOption exercise9,387—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related